Opendata, web and dolomites

CENSUS SIGNED

Cell-Based Models for Neurodegeneration Study and Use in Screening

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CENSUS project word cloud

Explore the words cloud of the CENSUS project. It provides you a very rough idea of what is the project "CENSUS" about.

cell    precision    combinations    manufacturing    peptide       tissue    shown    advantage    unprecedented    containing    delivered    global    biological    discovery    toolset    protocols    biology    models    skillset    familiar    se    neuronal    neurodegenerative    unsustainable    exceptional    ready    analytical    countries    inks    cells    comprising    care    human    convenience    proprietary    phenocell    burden    tools    disciplinary    outputs    manufacture    instrumentation    chemistry    ltd    click    utility    contributed    scaffolds    printer    dendrons    multiwell    assembles    screening    kits    generate    sme    realised    inter    industrial    sarl    pluripotent    trl    predictive    additive    3d    mature    output    patient    printable    glial    differentiation    reinstate    treatment    customised    innovative    first    validated    co    culture    made    healthcare    cryopreserved    stem    lineages    cryopreservation    clinical    assembled    biomaterials    single    disease    donor    commercial    plates    phenotypes    census    simpler    combination    cellink    neural    bio    supplying    unmet    uk    market    avanticell    ipsc    inclusion    situ    science    drug    formats   

Project "CENSUS" data sheet

The following table provides information about the project.

Coordinator
AvantiCell Science Ltd 

Organization address
address: GIBBSYARD BUILDING
city: AYR
postcode: KA6 5HW
website: www.avanticell.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.avanticell.com/technologies/projects/census
 Total cost 2˙561˙828 €
 EC max contribution 1˙793˙280 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
 Code Call H2020-FTIPilot-2016-1
 Funding Scheme IA
 Starting year 2016
 Duration (year-month-day) from 2016-10-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AvantiCell Science Ltd UK (AYR) coordinator 675˙736.00
2    CELLINK AB SE (GOTEBORG) participant 452˙943.00
3    PHENOCELL FR (GRASSE) participant 410˙850.00
4    TISSUE CLICK LTD UK (BRIGHTON) participant 253˙750.00

Map

 Project objective

1. Treatment of neurodegenerative disease is an unmet clinical challenge and patient care is a growing, unsustainable global healthcare burden. The project will produce novel tools to address this challenge. 2. The consortium will deliver a set of innovative analytical tools for neurodegenerative drug discovery using a combination of stem cell biology and novel biomaterials assembled by additive manufacturing. 3. The toolset will be analytical kits containing induced pluripotent stem cell (iPSC)-derived human neural cells in 3D culture formats, delivered to end-users in multiwell plates ready for industrial screening. 4. Project outputs will be realised by an inter-disciplinary consortium of four SME commercial partners in three European countries, each partner supplying a specific, essential skillset. 5. iPSC-derived neural cells will be produced by Phenocell sarl (F) using stem cell differentiation protocols already shown to generate glial or neuronal cell lineages, and to reinstate donor disease phenotypes. 6. Bio-printer instrumentation and printable bio-inks to manufacture 3D scaffolds enabling 3D cell culture will be contributed by Cellink (SE). 7. 3D culture models will be customised for neural/neurodegenerative cell culture by inclusion of peptide dendrons with biological functionality using mature chemistry proprietary to Tissue Click Ltd (UK). 8. Cell-based analysis products will be validated, and made user-friendly by in situ cell cryopreservation and analytical processes familiar to AvantiCell Science Ltd (UK). 9. Each contributing technology is at TRL 6, and each has commercial utility in simpler combinations. The project assembles them in first-to-market formats beyond the current state of the art. 10. The CENSUS project output, comprising iPSC-derived neural cells cryopreserved in single-cell and co-culture 3D formats will deliver exceptional analytical precision and predictive value, unprecedented end-user convenience and strong commercial advantage

 Deliverables

List of deliverables.
Documents defining technical performance and applications of 3D printed cell models Documents, reports 2020-03-27 10:43:50
CNS cell product and product information for dual cell-type model Demonstrators, pilots, prototypes 2020-03-27 10:43:50
CNS cell product and product information for single cell-type model Demonstrators, pilots, prototypes 2020-03-27 10:43:50

Take a look to the deliverables list in detail:  detailed list of CENSUS deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CENSUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CENSUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.)

Innovation Principle (2019)

Developing an Innovation-Friendly Legislative Culture – the Innovation Principle at Work

Read More  

PULSe (2017)

Pervasive Ubiquitous Lightwave SEnsor

Read More  

MedEye (2017)

Accelerated market launch of MedEye, a plug-and-play medication safety solution

Read More